Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes

Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diab...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cell and developmental biology 2021-12, Vol.9, p.777258-777258
Main Authors: Deng, Jianxin, Liao, Yunxiu, Liu, Jianpin, Liu, Wenjuan, Yan, Dewen
Format: Article
Language:English
Subjects:
Cell and Developmental Biology
diabetes
diabetic cardiomyopathy
epigenetics
hyperglycemia
methylation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243
cites cdi_FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243
container_end_page 777258
container_issue
container_start_page 777258
container_title Frontiers in cell and developmental biology
container_volume 9
creator Deng, Jianxin
Liao, Yunxiu
Liu, Jianpin
Liu, Wenjuan
Yan, Dewen
description Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diabetic populations. Diabetes is a polygenic, heritable, and complex condition that is exacerbated by environmental factors. Recent studies have demonstrated that epigenetics directly or indirectly contribute to pathogenesis. While epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs, have been recognized as key players in the pathogenesis of DCM, some of their impacts remain not well understood. Furthering our understanding of the roles played by epigenetics in DCM will provide novel avenues for DCM therapeutics and prevention strategies.
doi_str_mv 10.3389/fcell.2021.777258
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_645f9d213b114398b56d96ebae59f42a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_645f9d213b114398b56d96ebae59f42a</doaj_id><sourcerecordid>2618515133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243</originalsourceid><addsrcrecordid>eNpVkUtrGzEURkVpSEKSH5BNmWU3dvUYvTaF4qZtILSlpNCduHrZCuPRVBoH_O87E7shWUlXuvfcDw5C1wQvGVP6Q3Sh65YUU7KUUlKu3qBzSrVYCNb-efvifoauan3AGBPKJVfsFJ0xjnErpDpH33-FGqC4TfOz5HUJtTa5b26GtA59GJObyth8TmDnollB8Slv93mAcbNvUt_c74fQ0GNHqJfoJEJXw9XxvEC_v9zcr74t7n58vV19ulu4VvBxIaKPgCOxoJSW1ltJvfYgqCXeMW41J1RL54QXYK1rIwYnuWBTbq8sbdkFuj1wfYYHM5S0hbI3GZJ5eshlbaBMibtgRMuj9pQwS0jLtLJceC2ChcB1bClMrI8H1rCz2-Bd6McC3Svo658-bcw6PxolW0w0mwDvj4CS_-5CHc021dkO9CHvqqGCKE44YXMrObS6kmstIT6vIdjMWs2TVjNrNQet08y7l_meJ_5LZP8AEvOgGQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618515133</pqid></control><display><type>article</type><title>Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes</title><source>Open Access: PubMed Central</source><creator>Deng, Jianxin ; Liao, Yunxiu ; Liu, Jianpin ; Liu, Wenjuan ; Yan, Dewen</creator><creatorcontrib>Deng, Jianxin ; Liao, Yunxiu ; Liu, Jianpin ; Liu, Wenjuan ; Yan, Dewen</creatorcontrib><description>Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diabetic populations. Diabetes is a polygenic, heritable, and complex condition that is exacerbated by environmental factors. Recent studies have demonstrated that epigenetics directly or indirectly contribute to pathogenesis. While epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs, have been recognized as key players in the pathogenesis of DCM, some of their impacts remain not well understood. Furthering our understanding of the roles played by epigenetics in DCM will provide novel avenues for DCM therapeutics and prevention strategies.</description><identifier>ISSN: 2296-634X</identifier><identifier>EISSN: 2296-634X</identifier><identifier>DOI: 10.3389/fcell.2021.777258</identifier><identifier>PMID: 35004678</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Cell and Developmental Biology ; diabetes ; diabetic cardiomyopathy ; epigenetics ; hyperglycemia ; methylation</subject><ispartof>Frontiers in cell and developmental biology, 2021-12, Vol.9, p.777258-777258</ispartof><rights>Copyright © 2021 Deng, Liao, Liu, Liu and Yan.</rights><rights>Copyright © 2021 Deng, Liao, Liu, Liu and Yan. 2021 Deng, Liao, Liu, Liu and Yan</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243</citedby><cites>FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740193/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740193/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35004678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deng, Jianxin</creatorcontrib><creatorcontrib>Liao, Yunxiu</creatorcontrib><creatorcontrib>Liu, Jianpin</creatorcontrib><creatorcontrib>Liu, Wenjuan</creatorcontrib><creatorcontrib>Yan, Dewen</creatorcontrib><title>Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes</title><title>Frontiers in cell and developmental biology</title><addtitle>Front Cell Dev Biol</addtitle><description>Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diabetic populations. Diabetes is a polygenic, heritable, and complex condition that is exacerbated by environmental factors. Recent studies have demonstrated that epigenetics directly or indirectly contribute to pathogenesis. While epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs, have been recognized as key players in the pathogenesis of DCM, some of their impacts remain not well understood. Furthering our understanding of the roles played by epigenetics in DCM will provide novel avenues for DCM therapeutics and prevention strategies.</description><subject>Cell and Developmental Biology</subject><subject>diabetes</subject><subject>diabetic cardiomyopathy</subject><subject>epigenetics</subject><subject>hyperglycemia</subject><subject>methylation</subject><issn>2296-634X</issn><issn>2296-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtrGzEURkVpSEKSH5BNmWU3dvUYvTaF4qZtILSlpNCduHrZCuPRVBoH_O87E7shWUlXuvfcDw5C1wQvGVP6Q3Sh65YUU7KUUlKu3qBzSrVYCNb-efvifoauan3AGBPKJVfsFJ0xjnErpDpH33-FGqC4TfOz5HUJtTa5b26GtA59GJObyth8TmDnollB8Slv93mAcbNvUt_c74fQ0GNHqJfoJEJXw9XxvEC_v9zcr74t7n58vV19ulu4VvBxIaKPgCOxoJSW1ltJvfYgqCXeMW41J1RL54QXYK1rIwYnuWBTbq8sbdkFuj1wfYYHM5S0hbI3GZJ5eshlbaBMibtgRMuj9pQwS0jLtLJceC2ChcB1bClMrI8H1rCz2-Bd6McC3Svo658-bcw6PxolW0w0mwDvj4CS_-5CHc021dkO9CHvqqGCKE44YXMrObS6kmstIT6vIdjMWs2TVjNrNQet08y7l_meJ_5LZP8AEvOgGQ</recordid><startdate>20211224</startdate><enddate>20211224</enddate><creator>Deng, Jianxin</creator><creator>Liao, Yunxiu</creator><creator>Liu, Jianpin</creator><creator>Liu, Wenjuan</creator><creator>Yan, Dewen</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211224</creationdate><title>Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes</title><author>Deng, Jianxin ; Liao, Yunxiu ; Liu, Jianpin ; Liu, Wenjuan ; Yan, Dewen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cell and Developmental Biology</topic><topic>diabetes</topic><topic>diabetic cardiomyopathy</topic><topic>epigenetics</topic><topic>hyperglycemia</topic><topic>methylation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deng, Jianxin</creatorcontrib><creatorcontrib>Liao, Yunxiu</creatorcontrib><creatorcontrib>Liu, Jianpin</creatorcontrib><creatorcontrib>Liu, Wenjuan</creatorcontrib><creatorcontrib>Yan, Dewen</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in cell and developmental biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deng, Jianxin</au><au>Liao, Yunxiu</au><au>Liu, Jianpin</au><au>Liu, Wenjuan</au><au>Yan, Dewen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes</atitle><jtitle>Frontiers in cell and developmental biology</jtitle><addtitle>Front Cell Dev Biol</addtitle><date>2021-12-24</date><risdate>2021</risdate><volume>9</volume><spage>777258</spage><epage>777258</epage><pages>777258-777258</pages><issn>2296-634X</issn><eissn>2296-634X</eissn><abstract>Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diabetic populations. Diabetes is a polygenic, heritable, and complex condition that is exacerbated by environmental factors. Recent studies have demonstrated that epigenetics directly or indirectly contribute to pathogenesis. While epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs, have been recognized as key players in the pathogenesis of DCM, some of their impacts remain not well understood. Furthering our understanding of the roles played by epigenetics in DCM will provide novel avenues for DCM therapeutics and prevention strategies.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35004678</pmid><doi>10.3389/fcell.2021.777258</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-634X
ispartof Frontiers in cell and developmental biology, 2021-12, Vol.9, p.777258-777258
issn 2296-634X
2296-634X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_645f9d213b114398b56d96ebae59f42a
source Open Access: PubMed Central
subjects Cell and Developmental Biology
diabetes
diabetic cardiomyopathy
epigenetics
hyperglycemia
methylation
title Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A01%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20Progress%20on%20Epigenetics%20of%20Diabetic%20Cardiomyopathy%20in%20Type%202%20Diabetes&rft.jtitle=Frontiers%20in%20cell%20and%20developmental%20biology&rft.au=Deng,%20Jianxin&rft.date=2021-12-24&rft.volume=9&rft.spage=777258&rft.epage=777258&rft.pages=777258-777258&rft.issn=2296-634X&rft.eissn=2296-634X&rft_id=info:doi/10.3389/fcell.2021.777258&rft_dat=%3Cproquest_doaj_%3E2618515133%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-6fdfa0f1ba8897bdb72d9da62b1dc35b951297cc6d6abbc4f0ac7563350d8b243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618515133&rft_id=info:pmid/35004678&rfr_iscdi=true